284 related articles for article (PubMed ID: 20825689)
1. Anthelmintic resistance: markers for resistance, or susceptibility?
Beech RN; Skuce P; Bartley DJ; Martin RJ; Prichard RK; Gilleard JS
Parasitology; 2011 Feb; 138(2):160-74. PubMed ID: 20825689
[TBL] [Abstract][Full Text] [Related]
2. ABC transporters and beta-tubulin in macrocyclic lactone resistance: prospects for marker development.
Prichard RK; Roulet A
Parasitology; 2007; 134(Pt 8):1123-32. PubMed ID: 17608972
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein in helminths: function and perspectives for anthelmintic treatment and reversal of resistance.
Kerboeuf D; Blackhall W; Kaminsky R; von Samson-Himmelstjerna G
Int J Antimicrob Agents; 2003 Sep; 22(3):332-46. PubMed ID: 13678840
[TBL] [Abstract][Full Text] [Related]
4. ABC transporter modulation: a strategy to enhance the activity of macrocyclic lactone anthelmintics.
Lespine A; Alvinerie M; Vercruysse J; Prichard RK; Geldhof P
Trends Parasitol; 2008 Jul; 24(7):293-8. PubMed ID: 18514030
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of a relationship between macrocyclic lactone and benzimidazole anthelmintic selection on Haemonchus contortus.
de Lourdes Mottier M; Prichard RK
Pharmacogenet Genomics; 2008 Feb; 18(2):129-40. PubMed ID: 18192899
[TBL] [Abstract][Full Text] [Related]
6. Anthelmintic metabolism in parasitic helminths: proteomic insights.
Brophy PM; MacKintosh N; Morphew RM
Parasitology; 2012 Aug; 139(9):1205-17. PubMed ID: 22776506
[TBL] [Abstract][Full Text] [Related]
7. Benzimidazole-resistant beta-tubulin alleles in a population of parasitic nematodes (Cooperia oncophora) of cattle.
Winterrowd CA; Pomroy WE; Sangster NC; Johnson SS; Geary TG
Vet Parasitol; 2003 Nov; 117(3):161-72. PubMed ID: 14630425
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of anthelmintic resistance.
Sangster N
Parasitology; 1996; 113 Suppl():S201-16. PubMed ID: 9051936
[TBL] [Abstract][Full Text] [Related]
9. The biochemical basis of anthelmintic action and resistance.
Köhler P
Int J Parasitol; 2001 Apr; 31(4):336-45. PubMed ID: 11400692
[TBL] [Abstract][Full Text] [Related]
10. Interactions of Caenorhabditis elegans β-tubulins with the microtubule inhibitor and anthelmintic drug albendazole.
Pallotto LM; Dilks CM; Park YJ; Smit RB; Lu BT; Gopalakrishnan C; Gilleard JS; Andersen EC; Mains PE
Genetics; 2022 Jul; 221(4):. PubMed ID: 35731216
[TBL] [Abstract][Full Text] [Related]
11. The evolution of pentameric ligand-gated ion-channels and the changing family of anthelmintic drug targets.
Beech RN; Neveu C
Parasitology; 2015 Feb; 142(2):303-17. PubMed ID: 25354656
[TBL] [Abstract][Full Text] [Related]
12. Microtubules as target organelles for benzimidazole anthelmintic chemotherapy.
Gull K; Dawson PJ; Davis C; Byard EH
Biochem Soc Trans; 1987 Feb; 15(1):59-60. PubMed ID: 3556740
[No Abstract] [Full Text] [Related]
13. Development of amplicon sequencing for the analysis of benzimidazole resistance allele frequencies in field populations of gastrointestinal nematodes.
Sargison ND; MacLeay M; Morrison AA; Bartley DJ; Evans M; Chaudhry U
Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():92-100. PubMed ID: 31425900
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance mechanisms in helminths: is it survival of the fittest?
James CE; Hudson AL; Davey MW
Trends Parasitol; 2009 Jul; 25(7):328-35. PubMed ID: 19541539
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide Approaches to Investigate Anthelmintic Resistance.
Doyle SR; Cotton JA
Trends Parasitol; 2019 Apr; 35(4):289-301. PubMed ID: 30733094
[TBL] [Abstract][Full Text] [Related]
16. Will technology provide solutions for drug resistance in veterinary helminths?
von Samson-Himmelstjerna G; Blackhall W
Vet Parasitol; 2005 Sep; 132(3-4):223-39. PubMed ID: 16118040
[TBL] [Abstract][Full Text] [Related]
17. Managing anthelmintic resistance--parasite fitness, drug use strategy and the potential for reversion towards susceptibility.
Leathwick DM
Vet Parasitol; 2013 Nov; 198(1-2):145-53. PubMed ID: 24074608
[TBL] [Abstract][Full Text] [Related]
18. Molecular aspects of drug resistance in parasitic helminths.
Roos MH; Kwa MS; Veenstra JG; Kooyman FN; Boersema JH
Pharmacol Ther; 1993 Nov; 60(2):331-6. PubMed ID: 8022863
[TBL] [Abstract][Full Text] [Related]
19. Anthelmintic resistance in human helminths: a review.
Geerts S; Gryseels B
Trop Med Int Health; 2001 Nov; 6(11):915-21. PubMed ID: 11703846
[TBL] [Abstract][Full Text] [Related]
20. Cyclooctadepsipeptides--an anthelmintically active class of compounds exhibiting a novel mode of action.
Harder A; Schmitt-Wrede HP; Krücken J; Marinovski P; Wunderlich F; Willson J; Amliwala K; Holden-Dye L; Walker R
Int J Antimicrob Agents; 2003 Sep; 22(3):318-31. PubMed ID: 13678839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
